Bletterans, France

Sandrine Bouley

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents. Top assignees: Aventis Pharma S.a., National Institute of Health and Medical Research, Institut National Sante Et Recherche Medicale. Active years: 2011-2017.

USPTO Granted Patents = 3 


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Betterans, FR (2014)
  • Bletterans, FR (2011 - 2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sandrine Bouley: Innovator in Genetic Research

Introduction

Sandrine Bouley is a prominent inventor based in Bletterans, France. She has made significant contributions to the field of genetic research, particularly concerning the parkin gene. With a total of 3 patents to her name, her work has implications for therapeutic advancements.

Latest Patents

Bouley's latest patents focus on mutations of the parkin gene. The inventions involve nucleic acids that code for mutated or truncated forms of the human parkin gene, as well as forms that include multiplication of exons. These patents also encompass the corresponding proteins and antibodies. Additionally, her inventions provide methods and kits for identifying mutations of the parkin gene and for studying compounds for therapeutic purposes.

Career Highlights

Throughout her career, Sandrine Bouley has worked with notable organizations such as Aventis Pharma S.A. and the Institut National de la Santé et de la Recherche Médicale. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Some of her notable coworkers include Alexis Brice and Christophe Lucking. Their collaborative efforts have further enriched the research landscape in which Bouley operates.

Conclusion

Sandrine Bouley stands out as an influential figure in genetic research, with her innovative patents paving the way for future therapeutic developments. Her work continues to impact the understanding of the parkin gene and its associated mutations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…